STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ARTL ARTELO BIOSCIENCES INCORPORATED StockScouter® Report
4
StockScouter® Score
ARTELO BIOSCIENCES INCORPORATED, a micro cap company in the healthcare sector, is expected to underperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Shares are under accumulation by financial institutions. Marginally positive for a small company like ARTL
Concerns
- The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
- Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
F
C
N/A
D